DBDavide Baiamonte

Davide Baiamonte

*This is an algorithmically generated author record based on publicly available information.

Davide Baiamonte has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prestenting and its role in the URS: a study on the advantages it could have in intracorporeal lithotripsy interventions

    by Piero Mannone, Rosa Giaimo, Davide Baiamonte, Gianpaolo Di Gregorio, Gabriele Tulone, Pinelli Mirko, Nicola Pavan, Marco Vella, Alchiede Simonato

    Ureteroscopy (URS) represents the most used procedure in the treatment of urolithiasis, conversely ureteral stenting before URS is still a topic of scientific discussion. The aim of our study is to evaluate the possible benefits and uses of pre-stenting and if it can be used in the everyday practice. In our retrospective observational study, we collected data of patients undergoing URS for ureteral and renal lithiasis from January 2018 to December 2020 at our Department. Patients were stratified by procedure (ureterolithotripsy or URSL vs retrograde intrarenal surgery or RIRS) and by pre-stenting. We collected the patients' clinical characteristics and the timing of pre-stenting insertion. As outcomes variables, we analyzed the stone free rate (SFR), operating times (OT) and short-term complications. 244 patients were included in the study, 84 had undergone pre-stenting with a mean of 44.3±42.7 days before surgery, while 160 did not. Regarding OT there are no differences in URSL and in the RIRS of stones in the renal pelvis; considering the RIRS of caliceal stones it is observed how the OT are lower in pre-stenting patients undergoing RIRS of caliceal stones (mean 79.29±34.7 vs 91.08±53.8 mins, p=0.1) and in case of multiple caliceal stones (mean 83.24±31.2 vs 103.53±48.6 mins, p=0.1). No differences were reported in the SFR for every URSL subgroups while it is higher in patients undergoing RIRS with a pre-stenting (85% vs 75%, p=0.08). Regarding the short term complications, in the pre-stenting group fewer cases of post-operative pain (20.4% vs 39.6% p<0.02) and hematuria (14.8% vs 28.3% p=0.08) were reported. Our study is in accordance with the indications of guidelines which advise against the routine use of pre-stenting before URS. RIRS deserve a separate evaluation and our study, although considering the routine use of pre-stenting unnecessary, recognize its usefulness in achieving SFR and reducing intraoperative complications.

  • Open Access

    Criss-cross hemostatic suture in nephron sparing open surgery

    by Alchiede Simonato, Pinelli Mirko, Gabriele Tulone, Marco Vella, Rosa Giaimo, Piero Mannone, Davide Baiamonte, Nicola Pavan

    Surgery is the curative treatment for localized Renal Cancer Carcinoma (RCC). Nephron sparing surgery is the recommended treatment modality in patients with T1 tumors based on oncological and functional outcomes [1]. Patients with stage T1a renal cancer who have undergone conservative surgery have demonstrated better survival and functional outcomes [2]. Renorrhaphy and resection technique are important for the preservation of the renal function. To date no technique is clearly preferable, and the choice can be made based on preference and experience of the surgeon [5]. The criss-cross technique guarantees excellent haemostasis by limiting the insult on healthy renal parenchyma.

  • Open Access

    The potential role of Monocyte Distribution Width (MDW) as early post-operative sepsis biomarker

    by Davide Baiamonte, Silvia Altomare, Rosa Giaimo, Marco Vella, Piero Mannone, Pinelli Mirko, Gabriele Tulone, Luisa Agnello, Matteo Vidali, Bruna Lo Sasso, et al.

    Sepsis is one of the most dangerous post-operative complications. Recently, Monocyte Distribution Width (MDW), a blood test parameter able to measure morphological changes in monocytes, has been proposed and investigated as a new promising biomarker of sepsis. The aim of our study was to evaluate if MDW can be influenced by surgery to better understand if it could be use as a sepsis marker. All clinical and laboratories data were collected of all patients admitted from April to August 2021 to the Unit of Urology of our Department for elective kidney and ureteral stones surgery. The blood samples collected to evaluate MDW of each patient were analyzed on the UniCel DxH 900 analyzer (Beckman Coulter, Inc., USA), with an MDW value of 23 considered as significative value. Times of collection of blood samples were before surgery (BS), after surgery (AS) and at discharge time (DT) In all 66 patients enrolled in this study, while White Blood Cells (WBC) significantly increased after surgery (BS:7.95x109/L vs AS:11.4x109/L; p<0.001) with a trend to normalization at discharge (AS:11.40x109/L vs DT:9.90x109/L; p:0.021), there were no statistically significative differences for MDW (BS:17.6 vs AS:18.1; p:1) before and after surgery, as well comparing before surgery and at the time of discharge (BS:17.6 vs DT:18.5; p:0.237). In conclusion, MDW is not affected by surgical procedures and is easily measurable when compared to other biomarkers, considering that is part of a routine CBC. For these reasons, MDW could be a valid, cost-effective and fast biomarker to predict the risk of post-operative sepsis in elective surgery

  • Pre-operative risk assessment by ASA score and modified Frailty Index (mFI) in oncological and non oncological urological surgery

    by V. Serretta, F. Muffoletto, G. Tulone, S. Dioguardi, C. Guzzardo, S. Billeci, D. Baiamonte, S. Giannone, C. Sanfilippo, C. Scalici Gesolfo, et al.